Brief: Integra Lifesciences Announces Definitive Agreement To Acquire Surgical Innovation Associates (Sia) And Plans For $150 Million Share Repurchase

Integra LifeSciences Holdings

01/12/2022 13:14

Dec 1 (Reuters) - Integra Lifesciences Holdings Corp
 IART.O :
    * INTEGRA LIFESCIENCES ANNOUNCES DEFINITIVE AGREEMENT TO
ACQUIRE
SURGICAL INNOVATION ASSOCIATES (SIA) AND PLANS FOR $150 MILLION
SHARE REPURCHASE
    * INTEGRA LIFESCIENCES HOLDINGS CORP - WILL PURCHASE SIA FOR
$50
MILLION AT CLOSING
    * INTEGRA LIFESCIENCES HOLDINGS CORP - DOES NOT EXPECT THIS
ACQUISITION TO HAVE A MATERIAL FINANCIAL IMPACT IN 2022
    * INTEGRA LIFESCIENCES HOLDINGS CORP - TRANSACTION IS
EXPECTED TO
BE DILUTIVE TO ADJUSTED EARNINGS PER SHARE BY APPROXIMATELY
$0.06 IN YEAR 1
    * INTEGRA LIFESCIENCES HOLDINGS CORP - TRANSACTION IS
EXPECTED TO
BE ACCRETIVE TO EARNINGS IN YEAR 3
    * INTEGRA LIFESCIENCES HOLDINGS - DURASORB SALES TO BE
REPORTED
WITHIN CO'S TISSUE TECHNOLOGIES SEGMENT PART OF WOUND
RECONSTRUCTION AND CARE FRANCHISE
    * INTEGRA LIFESCIENCES HOLDINGS CORP - COMMENCEMENT OF SHARE
REPURCHASES IS EXPECTED TO OCCUR IN EARLY 2023

Source text for Eikon:  ID:nGNX6h6mQz 
Further company coverage:  IART.O 
 ((Reuters.Briefs@thomsonreuters.com;;))